Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Strategy

Bridge to innovation

Why Chinese biopharmas are building beachheads in Boston

September 29, 2017 11:17 PM UTC

While Zai Lab Ltd. has joined the ranks of Chinese biotechs making a splash on NASDAQ, less noticed may be the first wave of China-based players moving into Boston to jump-start their push into novel drug development.

This year has seen Chinese pharmas like Qilu Pharmaceutical Co. Ltd. and Luye Pharma Group Ltd. open R&D operations in the East Coast life sciences hub, viewing the city as a gateway to top-tier translational science and scientific talent as well as potential partners. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article